Literature DB >> 10364444

Intracranial injury acutely induces the expression of the secreted isoform of the CNS-specific hyaluronan-binding protein BEHAB/brevican.

D M Jaworski1, G M Kelly, S Hockfield.   

Abstract

Hyaluronan (HA) plays an important role in tissue reorganization in response to injury. The mechanisms by which HA participates in these processes are likely to include HA-binding proteins. Previously, we reported the cloning and initial characterization of a central nervous system (CNS)-specific HA-binding protein, BEHAB (brain enriched hyaluronan binding), which was independently cloned in another laboratory and named brevican. BEHAB/brevican mRNA is expressed in the ventricular zone coincident with the initial proliferation and migration of glial cells and in surgical samples of human glioma, where glial-derived cells proliferate and migrate. To determine whether BEHAB/brevican is also expressed during the cellular proliferation and migration associated with CNS injury, we have examined BEHAB/brevican expression during reactive gliosis. BEHAB/brevican occurs as secreted and cell-surface, glycosylphosphatidylinositol (GPI)-anchored, isoforms. The secreted, but not the GPI-anchored, isoform is up-regulated in response to a stab wound to the adult rat brain. The temporal regulation and spatial distribution of BEHAB/brevican expression parallel the gliotic response and the expression of the intermediate filament protein nestin. The up-regulation of BEHAB/brevican in response to CNS injury suggests a role for this extracellular matrix molecule in reactive gliosis. Glial process extension, a central element in the glial response to injury, may require the reexpression of both cytoskeletal and matrix elements that are normally expressed during the glial motility seen in the immature brain. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10364444     DOI: 10.1006/exnr.1999.7062

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  19 in total

1.  The chondroitin sulfate proteoglycans neurocan and phosphacan are expressed by reactive astrocytes in the chronic CNS glial scar.

Authors:  R J McKeon; M J Jurynec; C R Buck
Journal:  J Neurosci       Date:  1999-12-15       Impact factor: 6.167

2.  Tissue inhibitor of metalloproteinase-2(TIMP-2)-deficient mice display motor deficits.

Authors:  Diane M Jaworski; Paul Soloway; John Caterina; William A Falls
Journal:  J Neurobiol       Date:  2006-01

3.  Tissue inhibitor of metalloproteinase-2 promotes neuronal differentiation by acting as an anti-mitogenic signal.

Authors:  Leonor Pérez-Martínez; Diane M Jaworski
Journal:  J Neurosci       Date:  2005-05-18       Impact factor: 6.167

4.  Potential regulatory relationship between the nested gene DDC8 and its host gene tissue inhibitor of metalloproteinase-2.

Authors:  Diane M Jaworski; Micah Beem-Miller; Gentian Lluri; Ramiro Barrantes-Reynolds
Journal:  Physiol Genomics       Date:  2006-09-19       Impact factor: 3.107

5.  Pathological and molecular progression of astrocytomas in a GFAP:12 V-Ha-Ras mouse astrocytoma model.

Authors:  Patrick Shannon; Nesrin Sabha; Nelson Lau; Deepak Kamnasaran; David H Gutmann; Abhijit Guha
Journal:  Am J Pathol       Date:  2005-09       Impact factor: 4.307

6.  The proteoglycan brevican binds to fibronectin after proteolytic cleavage and promotes glioma cell motility.

Authors:  Bin Hu; Leopold L Kong; Russell T Matthews; Mariano S Viapiano
Journal:  J Biol Chem       Date:  2008-07-07       Impact factor: 5.157

7.  Traumatic brain injury results in disparate regions of chondroitin sulfate proteoglycan expression that are temporally limited.

Authors:  N G Harris; S T Carmichael; D A Hovda; R L Sutton
Journal:  J Neurosci Res       Date:  2009-10       Impact factor: 4.164

Review 8.  Sugar glues for broken neurons.

Authors:  Vimal P Swarup; Caitlin P Mencio; Vladimir Hlady; Balagurunathan Kuberan
Journal:  Biomol Concepts       Date:  2013-06

Review 9.  Hyaluronan as a therapeutic target in human diseases.

Authors:  Jiurong Liang; Dianhua Jiang; Paul W Noble
Journal:  Adv Drug Deliv Rev       Date:  2015-11-02       Impact factor: 15.470

Review 10.  Extracellular matrix and traumatic brain injury.

Authors:  Naijil George; Herbert M Geller
Journal:  J Neurosci Res       Date:  2018-01-18       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.